Nyhedsbrev
Tilmeld dig Innovationsfondens nyhedsbrev og få de seneste nyheder, søgemuligheder og arrangementer
| Titel Sortér faldende | Periode | Program | |
|---|---|---|---|
| Praice InnoBooster | 2015 - 2016 | Innobooster
|
|
|
Praice InnoBooster
Periode
2015 - 2016
Region
Region Hovedstaden Program
Innobooster Fagområde
Ikke defineret Investering
Percentage
20.76 Fondens investering
466.999 Samlet budget
2,2 mio. Projektdeltagere
PRAICE IVS Projektleder
PRAICE APS
Læs mere om projektet
| |||
| Pre-clinical exploration of cancer neoepitope immunotherapy | 2017 - 2020 | Erhvervsforsker
|
|
|
Pre-clinical exploration of cancer neoepitope immunotherapy
Periode
2017 - 2020
Region
Region Hovedstaden Program
Erhvervsforsker Fagområde
Biotek, Medico og Sundhed Investering
Percentage
44.19 Fondens investering
1,1 mio. Samlet budget
2,4 mio. Projektdeltagere
Technical University of Denmark, Evaxion Biotech Projektleder
Evaxion Biotech
Læs mere om projektet
| |||
| Pre-kliniske program for kræft præcision medicin | 2018 - 2021 | Grand Solutions
|
|
|
Pre-kliniske program for kræft præcision medicin
Periode
2018 - 2021
Region
Region Hovedstaden Program
Grand Solutions Fagområde
Biotek, Medico og Sundhed Investering
Percentage
71.93 Fondens investering
15,0 mio. Samlet budget
20,8 mio. Projektdeltagere
Prof. Janine Terra Erler, Rigshospitalet, Astra Zeneca, Roche A/S, Merck Sharp and Dohme Projektleder
BRIC, University of Copenhagen
Læs mere om projektet
| |||
| Pre-manufactured Elements in Wind Turbine Blades | 2022 - 2025 | Erhvervsforsker
|
|
|
Pre-manufactured Elements in Wind Turbine Blades
Periode
2022 - 2025
Region
Region Syddanmark Program
Erhvervsforsker Fagområde
Ikke defineret Investering
Percentage
46.35 Fondens investering
1,1 mio. Samlet budget
2,3 mio. Projektdeltagere
Technical University of Denmark, LM WIND POWER A/S Projektleder
LM WIND POWER A/S
Læs mere om projektet
| |||
| Precise genome editing in blood cells by in vivo delivery of the CRISPR system in lentivirus-derived nanoparticles | 2020 - 2023 | Erhvervsforsker
|
|
|
Precise genome editing in blood cells by in vivo delivery of the CRISPR system in lentivirus-derived nanoparticles
Periode
2020 - 2023
Region
Region Hovedstaden Program
Erhvervsforsker Fagområde
Biotek, Medico og Sundhed Investering
Percentage
52.55 Fondens investering
1,1 mio. Samlet budget
2,0 mio. Projektdeltagere
Aarhus University, Novo Nordisk A/S - G8, x9 m.fl. Projektleder
Novo Nordisk A/S - G8, x9 m.fl.
Læs mere om projektet
| |||
| Precision Brain-Circuit Therapy (Precision-BCT): Personalized multi-target brain stimulation to restore brain function in treatment-resistant depression Precision-BCT | 2019 - 2024 | Grand Solutions
|
|
|
Precision Brain-Circuit Therapy (Precision-BCT): Personalized multi-target brain stimulation to restore brain function in treatment-resistant depression Precision-BCT
Periode
2019 - 2024
Region
Region Hovedstaden Program
Grand Solutions Fagområde
Biotek, Medico og Sundhed Investering
Percentage
63.86 Fondens investering
14,2 mio. Samlet budget
22,2 mio. Projektdeltagere
Hvidovre Hospital, Magventure A/S, Technical University of Denmark, Psykiatrisk Center Glostrup, University Hospital Munich, Ludwig-Maximilian University, Localite GmbH Projektleder
Region Hovedstaden
Læs mere om projektet
| |||
| Precision Prebiotics | 2022 - 2025 | Erhvervsforsker
|
|
|
Precision Prebiotics
Periode
2022 - 2025
Region
Region Hovedstaden Program
Erhvervsforsker Fagområde
Ikke defineret Investering
Percentage
58.24 Fondens investering
1,1 mio. Samlet budget
1,8 mio. Projektdeltagere
Technical University of Denmark, Novozymes A/S Projektleder
Novozymes A/S
Læs mere om projektet
| |||
| Precision prebiotics for metabolic health and weight management utilizing a food waste stream from tamarind production. | 2025 - 2026 | Innofounder
|
|
|
Precision prebiotics for metabolic health and weight management utilizing a food waste stream from tamarind production.
Periode
2025 - 2026
Region
Program
Innofounder Fagområde
Ikke defineret Investering
Percentage
100 Fondens investering
430.000 Samlet budget
430.000 We need more fiber in our diets! A lack of fiber is linked to health issues like obesity, diabetes, and cardiovascular disease. On average, we consume only about half the recommended amount. While most people know they should eat more fruits, vegetables, and whole grains, many still fall short. Not all fibers are created equal. At Ora Biotics, we are developing Precision Prebiotics—natural fibers that are easy to incorporate into food products, making fiber intake convenient and enjoyable, ultimately promoting better health.
Our approach targets specific gut microbiome members and optimizes fermentation time to influence satiety and stimulate the release of satiety hormones in the gut and brain. By leveraging our expertise in fibers, human health, and food production, we create products that are efficient, targeted, and simple for food companies to integrate into their offerings.
Our first product focuses on weight management as a natural GLP-1 booster and gut microbiome enhancer. Sourced from a food side stream, it’s environmentally friendly and land-neutral while delivering precise health benefits.
Projektdeltagere
Ora Biotics Projektleder
Ora Biotics
Læs mere om projektet
| |||
| PreciSun | 2017 - 2018 | Innofounder
|
|
|
PreciSun
Periode
2017 - 2018
Region
Region Hovedstaden Program
Innofounder Fagområde
Ikke defineret Investering
Percentage
100 Fondens investering
215.000 Samlet budget
215.000 Projektdeltagere
Emix IVS Projektleder
Emix IVS
Læs mere om projektet
| |||
| Preclinical development of a synbiotic supplement to enhance early life immunity and diminish later development of inflammatory diseases. | 2022 - 2025 | Erhvervsforsker
|
|
|
Preclinical development of a synbiotic supplement to enhance early life immunity and diminish later development of inflammatory diseases.
Periode
2022 - 2025
Region
Region Hovedstaden Program
Erhvervsforsker Fagområde
Ikke defineret Investering
Percentage
32.53 Fondens investering
1,1 mio. Samlet budget
3,3 mio. Projektdeltagere
Technical University of Denmark, CHR HANSEN A/S Projektleder
CHR HANSEN A/S
Læs mere om projektet
| |||
| Preclinical evaluation of ImmPACT cell therapy for Merkel Cell Carcinoma | 2020 - 2022 | Erhvervsforsker
|
|
|
Preclinical evaluation of ImmPACT cell therapy for Merkel Cell Carcinoma
Periode
2020 - 2022
Region
Region Hovedstaden Program
Erhvervsforsker Fagområde
Biotek, Medico og Sundhed Investering
Percentage
100 Fondens investering
828.000 Samlet budget
828.000 Projektdeltagere
Technical University of Denmark, PokeAcell ApS Projektleder
PokeAcell ApS
Læs mere om projektet
| |||
| Preclinical models for checkpoint vaccines | 2015 - 2017 | Innobooster
|
|
|
Preclinical models for checkpoint vaccines
Periode
2015 - 2017
Region
Region Hovedstaden Program
Innobooster Fagområde
Ikke defineret Investering
Percentage
50 Fondens investering
2,0 mio. Samlet budget
4,1 mio. Projektdeltagere
IO BIOTECH ApS Projektleder
IO BIOTECH ApS
Læs mere om projektet
| |||
| PRECURE | 2020 - 2021 | Innobooster
|
|
|
PRECURE
Periode
2020 - 2021
Region
Region Hovedstaden Program
Innobooster Fagområde
Ikke defineret Investering
Percentage
100 Fondens investering
270.000 Samlet budget
270.000 Projektdeltagere
PreCure ApS Projektleder
PreCure ApS
Læs mere om projektet
| |||
| PreCure | 2017 - 2017 | Innobooster
|
|
|
PreCure
Periode
2017 - 2017
Region
Region Hovedstaden Program
Innobooster Fagområde
Ikke defineret Investering
Percentage
32.5 Fondens investering
94.250 Samlet budget
290.000 Projektdeltagere
PreCure IVS Projektleder
PreCure ApS
Læs mere om projektet
| |||
| PreCure 3 | 2018 - 2019 | Innobooster
|
|
|
PreCure 3
Periode
2018 - 2019
Region
Region Hovedstaden Program
Innobooster Fagområde
Ikke defineret Investering
Percentage
32.95 Fondens investering
473.213 Samlet budget
1,4 mio. Projektdeltagere
PreCure IVS Projektleder
PreCure ApS
Læs mere om projektet
| |||